✦ LIBER ✦

Clinical course and histopathologic risk factor assessment in patients with bilateral testicular germ cell tumors

✍ Scribed by Peter Albers; Alexander Göll; Erhard Bierhoff; Georg Schoeneich; Stefan C Müller

Book ID: 117266135
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 459 KB
Volume: 54
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(99)00285-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histopathological and biological prognos

Histopathological and biological prognostic risk factors in low stage testicular nonseminomatous germ cell tumors

✍ A. Heidenreich; I. A. Sesterhenn; F. K. Mostofi; J. W. Moul; U. H. Engelmann 📂 Article 📅 1999 🏛 Springer 🌐 German ⚖ 261 KB

Clinical characteristics, treatment and

Clinical characteristics, treatment and outcome of patients (pts) with bilateral testicular germ cell tumors (BTGCT)

✍ L. Geczi; F. Gomez; M. Bak; I. Bodrogi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB

BILATERAL TESTICULAR GERM CELL TUMOURS I

BILATERAL TESTICULAR GERM CELL TUMOURS IN TURKEY: LONG-TERM RESULTS AND RISK FACTORS IN 27 PATIENTS

✍ B. Akdogan; T. Divrik; S. Dogan; T. Tombul; F. Zorlu; C. Tasar; H. Ozen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Interrelationships of histopathology and

Interrelationships of histopathology and other clinical variables in patients with germ cell tumors of the testis

✍ George J. Bosl; Nancy Geller; C. Cirrincione; Steven I. Hajdu; Willet Whitmore J 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views

Serum tumor markers and patient allocati

Serum tumor markers and patient allocation to good-risk and poor-risk clinical trials in patients with germ cell tumors

✍ George J. Bosl; Nancy L. Geller; Dean Bajorin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

The allocation of patients with advanced germ cell tumors (GCT) to different treatment programs based on clinical characteristics is standard in the design of clinical trials today. Studies have shown that substantial differences exist between entry criteria and that these differences could influenc

MIB-1 immunohistochemistry in clinical S

MIB-1 immunohistochemistry in clinical Stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis

✍ Peter Albers; Erhard Bierhoff; Daniela Neu; Rolf Fimmers; Nicolas Wernert; Stefa 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

all patients underwent retroperitoneal lymph node dissection) were retrospectively cal Center,